Sedation during ventricular tachycardia treatment

Phase 1

• Conditions: Percutaneous pericardial access for mappingand ablation of ventricular tachycardia; Therapeutic area: Health Care [N] - Health Care Facilities, Manpower, and Services [N02]

• Registration Number: EUCTR2016-004455-78-SE
• Lead Sponsor: Region Östergötland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-04-11
• Last Update Posted: 13 November 2017

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Adults (>18 yr)
Patients in need of ablation for ventricular tachycardia
That the patients have given their signed consent to participate, after receiving information
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40

Exclusion Criteria

Known pregnancy or planning to be pregnant
Known allergy or contraindication to any of the studied drugs
Cognitive impairment, unwillingness or language difficulties that may impend the understanding of what participation in the study means or the operating of the PCS devise.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified